Efficacy and Safety of Mydriatic Microdrops for Retinopathy of Prematurity Screening: The MyMiROPS Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2024.5462
Abstract: Importance Commercial mydriatics administered in preterm infants during retinopathy of prematurity (ROP) screening have been associated with various cardiorespiratory and gastrointestinal adverse events. Objective To examine whether microdrops of a combined mixture of 1.67% phenylephrine… read more here.
Keywords: retinopathy prematurity; adverse events; standard drops; trial ... See more keywords